Citius Pharmaceuticals Inc (CTXR)vsRevolution Medicines Inc (RVMD)
CTXR
Citius Pharmaceuticals Inc
$0.53
-1.40%
HEALTHCARE · Cap: $14.69M
RVMD
Revolution Medicines Inc
$166.87
-3.15%
HEALTHCARE · Cap: $41.76B
Smart Verdict
WallStSmart Research — data-driven comparison
Revolution Medicines Inc generates 2680% more annual revenue ($197.56M vs $7.11M). RVMD leads profitability with a 0.0% profit margin vs 0.0%. CTXR earns a higher WallStSmart Score of 30/100 (F).
CTXR
Avoid30
out of 100
Grade: F
RVMD
Avoid23
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for CTXR.
Margin of Safety
+89.8%
Fair Value
$1883.88
Current Price
$166.87
$1717.01 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Trading at 15.0x book value
0.0% earnings growth
0.0% margin — thin
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : CTXR
The strongest argument for CTXR centers on Price/Book, Debt/Equity.
Bull Case : RVMD
The strongest argument for RVMD centers on Debt/Equity.
Bear Case : CTXR
The primary concerns for CTXR are Revenue Growth, EPS Growth, Market Cap.
Bear Case : RVMD
The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.
Key Dynamics to Monitor
RVMD carries more volatility with a beta of 1.43 — expect wider price swings.
CTXR is growing revenue faster at 0.0% — sustainability is the question.
CTXR generates stronger free cash flow (-9M), providing more financial flexibility.
Monitor BIOTECHNOLOGY industry trends, competitive dynamics, and regulatory changes.
Bottom Line
CTXR scores higher overall (30/100 vs 23/100). RVMD offers better value entry with a 89.8% margin of safety. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Citius Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and markets critical care products. The company is headquartered in Cranford, New Jersey.
Revolution Medicines Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?